United States Biotechnology & Medical Research

Rhythm Pharmaceuticals Inc (RYTM)

Track

Rhythm Pharmaceuticals Inc. has experienced significant insider selling activity recently, with executives and directors offloading shares totaling over 11 million dollars. These transactions occurred following a positive earnings report. Despite this divestment, the stock price has appreciated by 23.2 percent over the last quarter, currently trading near its fifty-two week high.
Ticker: RYTM Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Rhythm Pharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Proposed sale 11 Aug 2026
Value US$1,329,466.21 | Price 353.04 | Shares 38,928
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-11 2026-08-11 PrS Proposed sale
2.2
PAMELA CRAMER

Officer

Officer
38,928
353.04
US$1,329,466 		38,928 353.04 US$1,329,466
2026-08-10 2026-08-10 PrS Proposed sale
2.2
PAMELA CRAMER

Officer

Officer
50,146
464.21
US$1,644,267 		50,146 464.21 US$1,644,267
2026-06-24 2026-06-22 PlS Planned sale
2.8
TETRAULT LYNN A.
Non-Executive Director
64,345 +27.3%
329.38
US$2,709,802 		64,345 +27.3% 329.38 US$2,709,802
2026-06-22 2026-06-22 PrS Proposed sale
2.8
LYNN TETRAULT

Director

Non-Executive Director
37,000
96.79
US$3,581,230 		37,000 96.79 US$3,581,230
2026-06-22 2026-06-22 PrS Proposed sale
2.8
LYNN TETRAULT

Director

Non-Executive Director
37,000
96.79
US$3,581,230 		37,000 96.79 US$3,581,230
2026-05-19 2026-05-15 S Sale
German Christopher Paul

Corporate Controller & CAO

Officer
4,643 -100.0%
92.21
US$428,131 		4,643 -100.0% 92.21 US$428,131
2026-03-06 2026-03-04 PlS Planned sale
German Christopher Paul

Corporate Controller & CAO

Officer
5,614 -97.2%
89.56
US$502,790 		5,614 -97.2% 89.56 US$502,790
2026-03-04 2026-03-04 PrS Proposed sale
3.7
CAMILLE L BEDROSIAN

Director

Non-Executive Director
64,540
90.62
US$5,848,744 		64,540 90.62 US$5,848,744
2026-03-03 2026-03-03 PrS Proposed sale
3.7
CAMILLE L BEDROSIAN

Director

Non-Executive Director
35,460
90.52
US$3,209,779 		35,460 90.52 US$3,209,779
2026-02-19 2026-02-19 PlS Planned sale
Smith Hunter C

Chief Financial Officer

Officer
585 -0.5%
103.28
US$60,420 		585 -0.5% 103.28 US$60,420
2026-02-19 2026-02-19 PlS Planned sale
Smith Hunter C

Chief Financial Officer

Officer
800 -0.7%
102.10
US$81,676 		800 -0.7% 102.10 US$81,676
2026-02-19 2026-02-19 PlS Planned sale
Smith Hunter C

Chief Financial Officer

Officer
1,692 -1.5%
100.92
US$170,755 		1,692 -1.5% 100.92 US$170,755
2026-02-19 2026-02-19 PlS Planned sale
Smith Hunter C

Chief Financial Officer

Officer
1,308 -1.1%
100.27
US$131,153 		1,308 -1.1% 100.27 US$131,153
2026-02-19 2026-02-17 PlS Planned sale
Smith Hunter C

Chief Financial Officer

Officer
200 -0.2%
103.84
US$20,768 		200 -0.2% 103.84 US$20,768
2026-02-19 2026-02-17 PlS Planned sale
Smith Hunter C

Chief Financial Officer

Officer
1,069 -0.9%
103.00
US$110,110 		1,069 -0.9% 103.00 US$110,110
2026-02-19 2026-02-17 PlS Planned sale
Smith Hunter C

Chief Financial Officer

Officer
900 -0.8%
101.70
US$91,530 		900 -0.8% 101.70 US$91,530
2026-02-19 2026-02-17 PlS Planned sale
Smith Hunter C

Chief Financial Officer

Officer
200 -0.2%
100.52
US$20,104 		200 -0.2% 100.52 US$20,104
2026-02-19 2026-02-17 PlS Planned sale
Smith Hunter C

Chief Financial Officer

Officer
1,200 -1.0%
99.42
US$119,298 		1,200 -1.0% 99.42 US$119,298
2026-02-12 2026-02-12 PlS Planned sale
Smith Hunter C

Chief Financial Officer

Officer
100 -0.1%
100.10
US$10,010 		100 -0.1% 100.10 US$10,010
2026-02-12 2026-02-12 PlS Planned sale
Smith Hunter C

Chief Financial Officer

Officer
800 -0.7%
98.99
US$79,192 		800 -0.7% 98.99 US$79,192
2026-02-12 2026-02-12 PlS Planned sale
Smith Hunter C

Chief Financial Officer

Officer
400 -0.3%
97.67
US$39,069 		400 -0.3% 97.67 US$39,069
2026-02-12 2026-02-12 PlS Planned sale
Smith Hunter C

Chief Financial Officer

Officer
292 -0.2%
96.26
US$28,109 		292 -0.2% 96.26 US$28,109
2026-02-12 2026-02-11 PlS Planned sale
Smith Hunter C

Chief Financial Officer

Officer
100 -0.1%
100.85
US$10,085 		100 -0.1% 100.85 US$10,085
2026-02-12 2026-02-11 PlS Planned sale
Smith Hunter C

Chief Financial Officer

Officer
400 -0.3%
99.44
US$39,775 		400 -0.3% 99.44 US$39,775
2026-02-12 2026-02-11 PlS Planned sale
Smith Hunter C

Chief Financial Officer

Officer
2,266 -1.8%
98.37
US$222,906 		2,266 -1.8% 98.37 US$222,906
2026-02-12 2026-02-10 PlS Planned sale
Smith Hunter C

Chief Financial Officer

Officer
100 -0.1%
104.76
US$10,476 		100 -0.1% 104.76 US$10,476
2026-02-12 2026-02-10 PlS Planned sale
Smith Hunter C

Chief Financial Officer

Officer
700 -0.6%
103.68
US$72,574 		700 -0.6% 103.68 US$72,574
2026-02-12 2026-02-10 PlS Planned sale
Smith Hunter C

Chief Financial Officer

Officer
1,913 -1.5%
102.66
US$196,380 		1,913 -1.5% 102.66 US$196,380
2026-02-06 2026-02-05 PlS Planned sale
Smith Hunter C

Chief Financial Officer

Officer
3,381 -2.6%
106.06
US$358,599 		3,381 -2.6% 106.06 US$358,599
2026-02-05 2026-02-05 PrS Proposed sale
HUNTER SMITH

Officer

Officer
18,406
107.97
US$1,987,296 		18,406 107.97 US$1,987,296
2026-02-06 2026-02-04 PlS Planned sale
Smith Hunter C

Chief Financial Officer

Officer
747 -0.6%
107.67
US$80,426 		747 -0.6% 107.67 US$80,426
2026-02-06 2026-02-04 PlS Planned sale
Smith Hunter C

Chief Financial Officer

Officer
1,000 -0.8%
106.60
US$106,604 		1,000 -0.8% 106.60 US$106,604
2026-02-06 2026-02-04 PlS Planned sale
Smith Hunter C

Chief Financial Officer

Officer
1,500 -1.1%
104.74
US$157,115 		1,500 -1.1% 104.74 US$157,115
2026-02-04 2026-02-04 PrS Proposed sale
HUNTER SMITH

Officer

Officer
3,247
108.29
US$351,618 		3,247 108.29 US$351,618
2025-12-15 2025-12-11 PlS Planned sale
2.2
Cramer Pamela J.

Chief Human Resources Officer

Officer
3,350 -13.9%
111.00
US$371,850 		3,350 -13.9% 111.00 US$371,850
2025-12-11 2025-12-11 PrS Proposed sale
2.2
PAMELA CRAMER

Officer

Officer
3,350
104.77
US$350,980 		3,350 104.77 US$350,980
2025-11-24 2025-11-20 PlS Planned sale
2.2
Cramer Pamela J.

Chief Human Resources Officer

Officer
3,350 -13.9%
105.00
US$351,750 		3,350 -13.9% 105.00 US$351,750
2025-11-20 2025-11-20 PrS Proposed sale
2.2
PAMELA CRAMER

Officer

Officer
3,350
103.15
US$345,552 		3,350 103.15 US$345,552
2025-11-12 2025-11-10 PlS Planned sale
2.2
Cramer Pamela J.

Chief Human Resources Officer

Officer
3,515 -14.4%
100.00
US$351,500 		3,515 -14.4% 100.00 US$351,500
2025-11-10 2025-11-10 PrS Proposed sale
2.2
PAMELA CRAMER

Officer

Officer
3,515
100.30
US$352,554 		3,515 100.30 US$352,554
2025-11-12 2025-11-07 PlS Planned sale
2.2
Cramer Pamela J.

Chief Human Resources Officer

Officer
19,351 -48.2%
98.82
US$1,912,326 		19,351 -48.2% 98.82 US$1,912,326
2025-11-07 2025-11-07 PrS Proposed sale
2.2
PAMELA CRAMER

Officer

Officer
19,351
98.49
US$1,905,880 		19,351 98.49 US$1,905,880
2025-11-03 2025-10-30 PlS Planned sale
Shulman Joseph

Chief Technical Officer

Officer
9,748 -53.4%
115.24
US$1,123,398 		9,748 -53.4% 115.24 US$1,123,398
2025-10-30 2025-10-30 PrS Proposed sale
JOSEPH SHULMAN

Officer

Officer
9,748
113.89
US$1,110,200 		9,748 113.89 US$1,110,200
2025-10-30 2025-10-28 PlS Planned sale
Shulman Joseph

Chief Technical Officer

Officer
2,815 -24.9%
115.01
US$323,750 		2,815 -24.9% 115.01 US$323,750
2025-10-28 2025-10-28 PrS Proposed sale
JOSEPH SHULMAN

Officer

Officer
2,815
111.55
US$314,013 		2,815 111.55 US$314,013
2025-10-20 2025-10-16 PlS Planned sale
Shulman Joseph

Chief Technical Officer

Officer
3,412 -28.6%
112.81
US$384,908 		3,412 -28.6% 112.81 US$384,908
2025-10-20 2025-10-16 PlS Planned sale
Shulman Joseph

Chief Technical Officer

Officer
8,332 -41.1%
112.06
US$933,646 		8,332 -41.1% 112.06 US$933,646
2025-10-20 2025-10-16 PlS Planned sale
Shulman Joseph

Chief Technical Officer

Officer
2,693 -11.7%
110.95
US$298,784 		2,693 -11.7% 110.95 US$298,784
2025-10-16 2025-10-16 PrS Proposed sale
JOSEPH SHULMAN

Officer

Officer
14,437
109.35
US$1,578,686 		14,437 109.35 US$1,578,686
2025-09-04 2025-09-02 PlS Planned sale
Shulman Joseph

Chief Technical Officer

Officer
16,781 -66.4%
105.30
US$1,767,006 		16,781 -66.4% 105.30 US$1,767,006
2025-09-02 2025-09-02 PrS Proposed sale
JOSEPH SHULMAN

Officer

Officer
16,781
103.15
US$1,730,960 		16,781 103.15 US$1,730,960
2025-08-25 2025-08-21 PlS Planned sale
Shulman Joseph

Chief Technical Officer

Officer
4,188 -33.0%
100.07
US$419,091 		4,188 -33.0% 100.07 US$419,091
2025-08-21 2025-08-21 PrS Proposed sale
JOSEPH SHULMAN

Officer

Officer
4,188
98.70
US$413,356 		4,188 98.70 US$413,356
2025-08-14 2025-08-13 PlS Planned sale
Smith Hunter C

Chief Financial Officer

Officer
3,477 -2.9%
96.00
US$333,792 		3,477 -2.9% 96.00 US$333,792
2025-08-14 2025-08-12 PlS Planned sale
German Christopher Paul

Corporate Controller & CAO

Officer
1,500 -61.9%
95.00
US$142,500 		1,500 -61.9% 95.00 US$142,500
2025-08-14 2025-08-12 PlS Planned sale
Smith Hunter C

Chief Financial Officer

Officer
24,611 -17.4%
96.33
US$2,370,832 		24,611 -17.4% 96.33 US$2,370,832
2025-08-12 2025-08-12 PrS Proposed sale
HUNTER SMITH

Officer

Officer
28,088
94.31
US$2,648,979 		28,088 94.31 US$2,648,979
2025-08-12 2025-08-12 PrS Proposed sale
CHRISTOPHER PAUL GERMAN

Officer

Officer
1,500
94.31
US$141,465 		1,500 94.31 US$141,465
2025-08-13 2025-08-11 PlS Planned sale
Shulman Joseph

Chief Technical Officer

Officer
3,984 -31.9%
90.08
US$358,891 		3,984 -31.9% 90.08 US$358,891
2025-08-11 2025-08-11 PrS Proposed sale
JOSEPH SHULMAN

Officer

Officer
3,984
91.98
US$366,448 		3,984 91.98 US$366,448
2025-07-29 2025-07-29 PlS Planned sale
2.2
Cramer Pamela J.

Chief Human Resources Officer

Officer
1,520 -6.8%
85.93
US$130,614 		1,520 -6.8% 85.93 US$130,614
2025-07-11 2025-07-09 PlS Planned sale
German Christopher Paul

Corporate Controller & CAO

Officer
1,850 -66.7%
85.00
US$157,250 		1,850 -66.7% 85.00 US$157,250
2025-07-11 2025-07-09 PlS Planned sale
German Christopher Paul

Corporate Controller & CAO

Officer
1,967 -41.5%
76.75
US$150,967 		1,967 -41.5% 76.75 US$150,967
2025-07-11 2025-07-09 PlS Planned sale
Smith Hunter C

Chief Financial Officer

Officer
23,400 -16.7%
84.50
US$1,977,300 		23,400 -16.7% 84.50 US$1,977,300
2025-07-11 2025-07-09 PlS Planned sale
Smith Hunter C

Chief Financial Officer

Officer
1,607 -1.1%
76.17
US$122,406 		1,607 -1.1% 76.17 US$122,406
2025-07-11 2025-07-09 PlS Planned sale
Smith Hunter C

Chief Financial Officer

Officer
17,113 -10.8%
75.38
US$1,290,050 		17,113 -10.8% 75.38 US$1,290,050
2025-07-11 2025-07-09 PlS Planned sale
Shulman Joseph

Chief Technical Officer

Officer
3,985 -31.9%
80.00
US$318,800 		3,985 -31.9% 80.00 US$318,800
2025-07-11 2025-07-09 PlS Planned sale
Shulman Joseph

Chief Technical Officer

Officer
3,984 -24.2%
75.56
US$301,051 		3,984 -24.2% 75.56 US$301,051
2025-07-11 2025-07-09 PlS Planned sale
2.2
Cramer Pamela J.

Chief Human Resources Officer

Officer
3,516 -15.5%
80.00
US$281,280 		3,516 -15.5% 80.00 US$281,280
2025-07-11 2025-07-09 PlS Planned sale
2.2
Cramer Pamela J.

Chief Human Resources Officer

Officer
7,831 -25.6%
76.69
US$600,565 		7,831 -25.6% 76.69 US$600,565
2025-07-11 2025-07-09 PlS Planned sale
2.2
Cramer Pamela J.

Chief Human Resources Officer

Officer
4,225 -12.1%
75.55
US$319,217 		4,225 -12.1% 75.55 US$319,217
2025-07-09 2025-07-09 PrS Proposed sale
CHRISTOPHER PAUL GERMAN

Officer

Officer
3,817
65.14
US$248,639 		3,817 65.14 US$248,639
2025-07-09 2025-07-09 PrS Proposed sale
2.2
PAMELA CRAMER

Officer

Officer
15,572
65.14
US$1,014,360 		15,572 65.14 US$1,014,360
2025-07-09 2025-07-09 PrS Proposed sale
HUNTER SMITH

Officer

Officer
42,120
65.14
US$2,743,697 		42,120 65.14 US$2,743,697
Explore more

More insider trading research around Rhythm Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America